Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | CTSC | P53634 | 3/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.43 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | RGS12 | O14924 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16015165 | 0.85 | CYP3A4 (0.55) | CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL16015166 | 0.85 | CYP3A4 (0.55) | CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL16376134 | 0.85 | CYP3A4 (0.55) | CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL12333752 | 0.85 | CYP3A4 (0.55) | CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL16139975 | 0.85 | CYP3A4 (0.55) | CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL7313727 | 0.85 | RECQL (0.62) | CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL7313737 | 0.85 | RECQL (0.62) | CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9 | |
| SCHEMBL976838 | 0.85 | RECQL (0.62) | CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9 | |
| Hydrochloric Acid SCHEMBL20489442 | 0.84 | RECQL (0.61) | CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9 | |
| Hydrochloric Acid SCHEMBL20489444 | 0.84 | RECQL (0.61) | CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8829208-B2 | Process for the preparation of darunavir and darunavir intermediates | MAPI PHARMA LTD. (IL) | 2014-09-09 | — | — | US | disclosed |
| US-20120296101-A1 | PROCESS FOR THE PREPARATION OF DARUNAVIR AND DARUNAVIR INTERMEDIATES | MAPI PHARMA LIMITED (IL) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120296101-A1 | PROCESS FOR THE PREPARATION OF DARUNAVIR AND DARUNAVIR INTERMEDIATES | CYP3A43, CYP3A4, DHPS | CYP3A4 2/4885CYP2D6 12/4885CYP2C19 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.